• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Teva Pharmaceuticals

Richard Francis Teva CEO Teva CEO
Pharma

Teva's 1st R&D day lets CEO bask in innovative drug refresh

TD Cowen analysts left Teva's first R&D day this week feeling “increasingly confident” in the firm’s direction.
Fraiser Kansteiner , Donavyn Coffey Nov 13, 2026 11:16am
closed close

Teva to shut down 'underutilized' New Jersey drug facility

Oct 27, 2026 4:17pm
Podcast
A blue-toned graphic showing assorted pills and capsules scattered across a close-up of a 100 bill with Benjamin Franklin

Inside Teva's Weltruza launch and Novo's GLP-1 strategy

Oct 16, 2026 9:29am
A puzzle of the brain with one missing piece

Teva bags long-sought reformulated olanzapine schizophrenia nod

Oct 9, 2026 9:56am
law and order concept

Courts reject Medicare price negotiation lawsuits from Merck, AZ

Aug 24, 2026 3:47pm
scales of justice

Appeals court sides partially with Teva in IRA pricing lawsuit

Aug 19, 2026 7:45am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings